DK278284D0 - Substituerede lactam-derivater til anvendelse som angiotensinase- eller enkephalinase-inhibitorer og fremgangsmaade til fremstilling af saadanne derivater - Google Patents
Substituerede lactam-derivater til anvendelse som angiotensinase- eller enkephalinase-inhibitorer og fremgangsmaade til fremstilling af saadanne derivaterInfo
- Publication number
- DK278284D0 DK278284D0 DK278284A DK278284A DK278284D0 DK 278284 D0 DK278284 D0 DK 278284D0 DK 278284 A DK278284 A DK 278284A DK 278284 A DK278284 A DK 278284A DK 278284 D0 DK278284 D0 DK 278284D0
- Authority
- DK
- Denmark
- Prior art keywords
- derivatives
- encyphalinase
- angiotensinase
- inhibitors
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
- C07D223/10—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/502,861 US4552889A (en) | 1983-06-09 | 1983-06-09 | 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension |
Publications (2)
Publication Number | Publication Date |
---|---|
DK278284D0 true DK278284D0 (da) | 1984-06-06 |
DK278284A DK278284A (da) | 1984-12-10 |
Family
ID=23999718
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK278284A DK278284A (da) | 1983-06-09 | 1984-06-06 | Substituerede lactam-derivater til anvendelse som angiotensinase- eller enkephalinase-inhibitorer og fremgangsmaade til fremstilling af saadanne derivater |
Country Status (10)
Country | Link |
---|---|
US (1) | US4552889A (da) |
EP (1) | EP0128728A1 (da) |
JP (1) | JPS608260A (da) |
KR (1) | KR860001957B1 (da) |
CA (1) | CA1215363A (da) |
DK (1) | DK278284A (da) |
GB (1) | GB2141120B (da) |
GR (1) | GR82360B (da) |
HU (1) | HU193288B (da) |
IL (1) | IL72021A (da) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075302A (en) * | 1990-03-09 | 1991-12-24 | Schering Corporation | Mercaptoacyl aminolactam endopeptidase inhibitors |
US5430145A (en) * | 1990-10-18 | 1995-07-04 | Merrell Dow Pharmaceuticals Inc. | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
US5308841A (en) * | 1990-12-21 | 1994-05-03 | Merrell Dow Pharmaceuticals Inc. | Amino and nitro containing tricyclic compounds useful as inhibitors of ACE |
AU657793B2 (en) * | 1991-09-27 | 1995-03-23 | Merrell Pharmaceuticals Inc. | Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
US5457196A (en) * | 1991-09-27 | 1995-10-10 | Merrell Dow Pharmaceuticals Inc. | 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE |
US5455242A (en) * | 1991-09-27 | 1995-10-03 | Merrell Dow Pharmaceuticals Inc. | Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace |
CA2078759C (en) * | 1991-09-27 | 2003-09-16 | Alan M. Warshawsky | Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
DK0534363T3 (da) * | 1991-09-27 | 1997-09-22 | Merrell Pharma Inc | 2-substituerede indan-2-mercaptoacetylamid-forbindelse med inhiberende virkning på enkephalinase og ACE. |
US5244889A (en) * | 1991-11-26 | 1993-09-14 | Ciba-Geigy Corporation | Certain macrocyclic lactam derivatives |
AU668707B2 (en) * | 1992-02-14 | 1996-05-16 | Merrell Pharmaceuticals Inc. | Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE |
WO1993023403A1 (en) * | 1992-05-15 | 1993-11-25 | Merrell Dow Pharmaceuticals Inc. | NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE |
US5420271A (en) * | 1992-08-24 | 1995-05-30 | Merrell Dow Pharmaceuticals, Inc. | 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
NZ256589A (en) * | 1992-10-30 | 1996-05-28 | Merrell Dow Pharma | Condensed azepine analogues and medicaments (where a is c, o or s and b is o or s) |
DE69416873T2 (de) * | 1994-02-14 | 1999-07-29 | Merrell Pharmaceuticals Inc., Cincinnati, Ohio | Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren |
CA2183314C (en) * | 1994-02-14 | 1999-08-31 | Gary A. Flynn | Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
HUT74584A (en) * | 1994-02-14 | 1997-01-28 | Merrell Pharma Inc | Novel heterocycle fused benzazepine-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase, process for producing them and pharmaceutical compositions containing them |
PT750631E (pt) * | 1994-02-14 | 2000-07-31 | Merrell Pharma Inc | Novos derivados de dissulfureto de mercapto-aacetilamido-1,3,4,5-tetra-hidro-benzo¬c)azepin-3-ona uteis como inibidores de encefalinase e ace |
US5530013A (en) * | 1994-02-14 | 1996-06-25 | American Home Products Corporation | Venlafaxine in the inducement of cognition enhancement |
US5484783A (en) * | 1994-03-24 | 1996-01-16 | Merrell Dow Pharmaceuticals Inc. | Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives |
DK0751774T3 (da) * | 1994-03-24 | 2003-12-08 | Merrell Pharma Inc | Hypocholesterolæmiske mercaptoacetylamiddisulfid-derivater |
DE69514912T2 (de) * | 1994-03-24 | 2000-10-05 | Merrell Pharmaceuticals Inc., Cincinnati | Hypocholesterolemische, antiatherosklerotische und hypotriglyceridemische verwendung von aminoacetylmercapto derivaten |
US5587375A (en) * | 1995-02-17 | 1996-12-24 | Bristol-Myers Squibb Company | Azepinone compounds useful in the inhibition of ACE and NEP |
US6686477B2 (en) * | 2000-09-29 | 2004-02-03 | Eastman Chemical Company | Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
GB0119305D0 (en) | 2001-04-12 | 2001-10-03 | Aventis Pharma Gmbh | Mercaptoacetylamide derivatives,a process for their preparation and their use |
GR1004905B (el) * | 2004-07-14 | 2005-05-27 | Ε.Ι.Ε. (Εθνικο Ιδρυμα Ερευνων) | Καινοτομα αντιυπερτασικα προιοντα |
JP2006347581A (ja) * | 2005-06-15 | 2006-12-28 | Shizuko Kobayashi | 包装体 |
KR20160022510A (ko) | 2014-08-20 | 2016-03-02 | 한국전자통신연구원 | 원심압축기의 서지 방지 장치 및 방법 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105776A (en) * | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
US4052511A (en) * | 1976-02-13 | 1977-10-04 | E. R. Squibb & Sons, Inc. | Carboxyacylproline derivatives |
US4046889A (en) * | 1976-02-13 | 1977-09-06 | E. R. Squibb & Sons, Inc. | Azetidine-2-carboxylic acid derivatives |
US4070361A (en) * | 1977-04-21 | 1978-01-24 | E. R. Squibb & Sons, Inc. | Mercaptoalkylsulfonyl proline and pipecolic acid and esters thereof |
IT1105731B (it) * | 1977-06-29 | 1985-11-04 | Yoshitomi Pharmaceutical | Composti di tiazolidina |
US4151172A (en) * | 1977-08-11 | 1979-04-24 | E. R. Squibb & Sons, Inc. | Phosphonoacyl prolines and related compounds |
US4283407A (en) * | 1977-09-28 | 1981-08-11 | Science Union Et Cie | Thiopropionamides, and the pharmaceutical compositions |
IT7851510A0 (it) * | 1977-10-28 | 1978-10-16 | Sandoz Ag | Ammidi di amminoacidi ciclici loro preparazione e loro applicazione quali medicamenti |
CA1120400A (en) * | 1977-12-27 | 1982-03-23 | Zola P. Horovitz | Method of treating hypertension and medicaments therefor |
EP0049500B1 (de) * | 1979-04-30 | 1984-02-22 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Tyrosinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Synthese von Peptiden |
EP0049842B1 (en) * | 1980-10-06 | 1985-08-28 | Merck & Co. Inc. | Substituted enantholactam derivatives, a process for the preparation and a pharmaceutical composition useful in the treatment of hypertension comprising the same, and intermediates |
EP0049505A3 (en) * | 1980-10-06 | 1982-08-04 | Merck & Co. Inc. | Substituted caprolactam derivatives, a process for preparing and a pharmaceutical composition containing the same, and intermediates |
US4415496A (en) * | 1981-03-23 | 1983-11-15 | Merck & Co., Inc. | Bicyclic lactams |
-
1983
- 1983-06-09 US US06/502,861 patent/US4552889A/en not_active Expired - Fee Related
-
1984
- 1984-06-04 IL IL72021A patent/IL72021A/xx not_active IP Right Cessation
- 1984-06-04 JP JP59115353A patent/JPS608260A/ja active Pending
- 1984-06-05 GB GB08414365A patent/GB2141120B/en not_active Expired
- 1984-06-05 EP EP84303771A patent/EP0128728A1/en not_active Withdrawn
- 1984-06-05 GR GR74925A patent/GR82360B/el unknown
- 1984-06-06 DK DK278284A patent/DK278284A/da not_active Application Discontinuation
- 1984-06-06 CA CA000456008A patent/CA1215363A/en not_active Expired
- 1984-06-07 KR KR1019840003185A patent/KR860001957B1/ko active IP Right Grant
- 1984-06-08 HU HU842222A patent/HU193288B/hu unknown
Also Published As
Publication number | Publication date |
---|---|
GR82360B (da) | 1984-12-13 |
GB2141120B (en) | 1986-10-15 |
GB2141120A (en) | 1984-12-12 |
JPS608260A (ja) | 1985-01-17 |
US4552889A (en) | 1985-11-12 |
HU193288B (en) | 1987-09-28 |
CA1215363A (en) | 1986-12-16 |
HUT34164A (en) | 1985-02-28 |
DK278284A (da) | 1984-12-10 |
GB8414365D0 (en) | 1984-07-11 |
EP0128728A1 (en) | 1984-12-19 |
KR860001957B1 (ko) | 1986-11-05 |
IL72021A (en) | 1988-05-31 |
KR850000392A (ko) | 1985-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK278284A (da) | Substituerede lactam-derivater til anvendelse som angiotensinase- eller enkephalinase-inhibitorer og fremgangsmaade til fremstilling af saadanne derivater | |
DK453789A (da) | Fremgangsmaade til paavirkning af azopigmenters triboelektriske effekt | |
DK155984D0 (da) | Fremgangsmade til fremstilling af thiadiazolderivater | |
DK298584D0 (da) | 2-sulfamoylbenzo(b)thiophenderivat og ophthalmisk praeparat indeholdende en saadan forbindelse samt fremgangsmaade til fremstilling af forbindelsen | |
DK375987D0 (da) | Fremgangsmaade til fremstilling af cycloalkyl-sub-stituerede 4-pyridyl derivater | |
DK140584A (da) | Fremgangsmaade til fremstilling af carbapenemderivater | |
DK312584A (da) | Fremgangsmaade til fremstilling af quinonderivater | |
DK549087A (da) | Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme | |
DK30489D0 (da) | Fremgangsmaade til fremstilling af pyranderivater | |
DK537687A (da) | Fremgangsmaade til fremstilling af n-substituerede piperazinoner | |
DK423284A (da) | Naphthalenylimidazopyridin og derivater heraf samt fremgangsmaade til fremstilling af saadanne forbindelser | |
DK314988A (da) | Fremgangsmaade til fremstilling af 6-deoxyguaninderivater | |
DK287484D0 (da) | Fremgangsmaade til fremstilling af acetaldehyd | |
DK7783A (da) | Fremgangsmaade til fremstilling af beta-lactamase-inhibitorer og kompositioner indeholdende saadanne, samt mellemprodukter for inhibitorerne | |
DK97388D0 (da) | Mellemprodukt og fremgangsmaade til fremstilling af antihypercholestrolemiske tetrazolforbindelser | |
DK32884A (da) | Fremgangsmaade til fremstilling af riboflavin | |
DK293589A (da) | Fremgangsmaade til fremstiling af lactolderivater | |
DK605384D0 (da) | Fremgangsmaade til fremstilling af azetidinoner | |
DK184789A (da) | Fremgangsmaade til fremstilling af naphthalenderivater | |
DK599689A (da) | Fremgangsmaade til fremstilling af naphthalenderivater | |
DK649088A (da) | Fremgangsmaade til fremstilling af alkanolaminderivater | |
DK130992A (da) | Fremgangsmaade til fremstilling af angiotenxinomdannende enzyminhibitorer | |
DK157874C (da) | Fremgangsmaade til fremstilling af azinomethylrifamyciner | |
DK165784C (da) | Fremgangsmaade til fremstilling af alkylendiaminderivater | |
DK133683A (da) | Fremgangsmaade til fremstilling af phenylethylenderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |